The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective

Background. Questions remain about the therapeutic durability of transoral incisionless fundoplication (TIF). In this study, clinical outcomes were evaluated at 5 years post-TIF 2.0. Methods. A total of 63 chronic gastroesophageal reflux disease (GERD) sufferers with troublesome symptoms refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Trad, Karim S., Barnes, William E., Prevou, Elizabeth R., Simoni, Gilbert, Steffen, Jennifer A., Shughoury, Ahmad B., Raza, Mamoon, Heise, Jeffrey A., Fox, Mark A., Mavrelis, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946656/
https://www.ncbi.nlm.nih.gov/pubmed/29405886
http://dx.doi.org/10.1177/1553350618755214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946656/
https://www.ncbi.nlm.nih.gov/pubmed/29405886
http://dx.doi.org/10.1177/1553350618755214

Ejemplares similares